Tabby offers flexible payment solutions for online shopping. Based in the United Arab Emirates, it enables users to pay for purchases in deferred single payments or installments.
Golden Goose
Venture Round in 2025
Golden Goose SpA is a prominent luxury fashion brand known for its unique and distinctive approach to footwear, particularly its iconic sneakers. The company specializes in the design, production, and sale of a wide range of products, including clothing, accessories, and bags. With a strong presence in the fashion industry, Golden Goose has gained recognition for its blend of craftsmanship and contemporary style, appealing to a diverse clientele that values both luxury and individuality.
Cambium Carbon
Seed Round in 2023
Cambium Carbon is an early-stage social enterprise focused on addressing climate change through innovative reforestation and urban wood reuse initiatives. The company collaborates with cities and various public and private partners to salvage fallen city trees that would otherwise end up in landfills. By transforming this wood waste into valuable resources, Cambium Carbon establishes reforestation hubs that create a circular economy for urban forests. These hubs not only generate revenue to support tree planting and maintenance projects but also foster sustainable job creation and contribute to the development of resilient urban environments. Through its efforts, Cambium Carbon aims to implement systems-level natural climate solutions that benefit both the environment and local communities.
Tabby offers flexible payment solutions for online shopping. Based in the United Arab Emirates, it enables users to pay for purchases in deferred single payments or installments.
GetYourGuide
Series F in 2023
GetYourGuide operates an online platform facilitating bookings of global tours, attractions, and activities. It connects customers with providers, charging a revenue share for each transaction. The platform features customer reviews to assess tour quality and removes poorly rated providers.
Artifact Labs
Seed Round in 2023
Artifact Labs is a pioneering company specializing in Web3 and non-fungible token (NFT) technology. It develops and operates a multi-chain NFT ecosystem, enabling organizations to transform physical assets into digital collections on the blockchain. By preserving historical records and raising awareness of cultural heritage, Artifact Labs helps organizations tap into new revenue streams to support their preservation efforts.
Premier Lacrosse League
Series D in 2022
The Premier Lacrosse League is a professional lacrosse organization that operates a tour-based league featuring top-tier teams and players. It aims to bring lacrosse to a national stage, providing fans with an entertaining sports experience.
LifeMine Therapeutics
Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.
Aver is a decentralized peer-to-peer betting exchange built on the Solana blockchain and the world’s first decentralized Web3 betting exchange.
Artemis
Pre Seed Round in 2021
Artemis is a decentralized mobile-focused NFT social and trading platform.
Animoca Brands
Venture Round in 2021
Animoca Brands is a venture capital firm focused on driving digital property rights to gamers and internet users through non-fungible tokens (NFTs). It leverages gamification and blockchain technology to develop, market, and invest in mobile applications, games, and additional products centered around educational learning, ensuring transparency, security, and new business models.
LifeMine Therapeutics
Series B in 2021
LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.
FogPharma
Venture Round in 2021
FogPharma is a biotechnology company focused on developing innovative therapies for cancer treatment through its proprietary cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, a leader in drug discovery, the company aims to target cancer-causing proteins within cells that are typically inaccessible to traditional drugs. This novel approach allows for the neutralization of these proteins, potentially transforming the treatment landscape for cancer-related diseases. FogPharma collaborates with leading experts in cancer biology and therapy, fostering a network of researchers, investors, and cancer patients dedicated to advancing its mission. The company is committed to delivering this new class of medicines to improve patient outcomes and enhance quality of life for individuals affected by cancer.
PlayVS operates a platform that organizes and facilitates online esports tournaments and wagers for cash prizes among high school students. It enables teen gamers to form teams, compete with other schools, and vie for state championship titles.
Brii Biosciences
Venture Round in 2018
Founded in 2018, Brii Biosciences is a biotechnology company dedicated to researching, developing, and commercializing medicines for chronic illnesses, with a primary focus on infectious diseases. Headquartered in Durham, North Carolina, the company operates additional offices in Shanghai and Beijing, China; and San Francisco, California.
GRAIL focuses on developing technologies for early cancer detection. Founded in 2016, the company specializes in a pan-cancer screening test that measures circulating nucleic acids in blood using high-intensity sequencing.
FogPharma
Series B in 2018
FogPharma is a biotechnology company focused on developing innovative therapies for cancer treatment through its proprietary cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, a leader in drug discovery, the company aims to target cancer-causing proteins within cells that are typically inaccessible to traditional drugs. This novel approach allows for the neutralization of these proteins, potentially transforming the treatment landscape for cancer-related diseases. FogPharma collaborates with leading experts in cancer biology and therapy, fostering a network of researchers, investors, and cancer patients dedicated to advancing its mission. The company is committed to delivering this new class of medicines to improve patient outcomes and enhance quality of life for individuals affected by cancer.
Hua Medicine
Series D in 2018
Hua Medicine is a clinical-stage drug development company in China focused on therapies for diabetes and CNS disorders. It develops Dorzagliatin (also known as HMS5552), an oral, first-in-class glucokinase activator for type 2 diabetes, and has advanced Dorzagliatin into NDA-enabling work and Phase III trials in China, including studies in drug-naive and metformin-treated patients. The company is pursuing Dorzagliatin in combination with metformin and in combination with DPP-4 inhibitors, SGLT-2 inhibitors, and insulin in various development stages. In addition, Hua Medicine is developing mGluR5 candidates for Parkinson's disease and related levodopa-induced dyskinesia. The company was founded in 2011 and is headquartered in Shanghai, China.
Rent The Runway
Venture Round in 2018
Rent the Runway, Inc. is an e-commerce platform that allows women to rent designer apparel and accessories, offering a transformative approach to fashion consumption. Founded in 2008 and based in New York, the company provides a range of options including party dresses, gowns, jumpsuits, outerwear, and accessories such as jewelry and handbags. Rent the Runway operates both an online platform and physical stores in locations like New York City, San Francisco, Santa Monica, and Washington, D.C. Through its subscription model, users can access an extensive collection of clothing for various occasions, while also having the option to rent items a-la-carte or purchase them outright. The company emphasizes sustainability and empowerment, catering to modern women's needs in a rapidly evolving fashion landscape.
LifeMine Therapeutics
Series A in 2017
LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.
Lytro is a pioneering company focused on developing advanced Light Field imaging platform technologies, enabling artists, scientists, and innovators to achieve unprecedented creative freedom and control. Founded in 2006 by Ren Ng, who earned recognition for his groundbreaking Ph.D. research in Light Field imaging, Lytro introduced its first consumer Light Field camera in 2012. This was followed by the release of the Lytro ILLUM and associated software tools in 2014, which expanded the application of Light Field technology beyond photography to various fields, including cinematography and industrial uses. In 2015, Lytro further diversified its offerings by entering the realms of virtual reality and scientific applications, establishing itself as a central player in a new technology ecosystem. With a commitment to enhancing visual quality and creative possibilities, Lytro’s products allow users to capture multi-dimensional data from multiple angles, thereby transforming the landscape of computational imaging. The company is headquartered in Mountain View, California.
Fanatics is a global sports merchandise company that designs, produces, distributes and retails licensed sports apparel, jerseys and fan gear through online, mobile and physical stores. Founded in 1995 and based in Jacksonville, Florida, the company operates a multi-channel platform that serves professional leagues, teams, media brands, collegiate and professional properties, and retailers, delivering high-quality merchandise to fans with real-time availability across channels.